LSA
MRNA icon

Leonteq Securities AG’s Moderna MRNA Stock Holding History

Leonteq Securities AG’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,000
Closed -$864K – 1349
2026
Q1 		$864K Hold
17,000
– – 0.03% 315
2025
Q4 		$501K Buy
+17,000
New +$462K 0.02% 460

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Leonteq Securities AG's MRNA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Moderna (MRNA) stake by 12% in Q2 2026, selling an estimated $1.82M and leaving 267,131 shares worth $18.7M. The position accounts for 0.64% of the portfolio, ranked #35.

Leonteq Securities AG first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $43.1M in Q2 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Leonteq Securities AG held 267,131 shares of Moderna worth $18.7M as of Q2 2026.
  • Leonteq Securities AG sold 35,244 Moderna shares in Q2 2026, an estimated $1.82M.
  • Moderna made up 0.64% of Leonteq Securities AG's portfolio in Q2 2026, its #35 holding.
  • Leonteq Securities AG first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Moderna position peaked at $43.1M in Q2 2022.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.